Daratumumab-based therapy after prior Azacytidine-Venetoclax in an octagenerian female with BPDCN (blastic plasmacytoid dendritic cell neoplasm) – a new perspective

Authors:

Abstract
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare malignancy derived from a hematopoietic stem cell, with plasmacytoid dendritic cells as their normal counterpart. BPDCN is enlisted as...

This publication has 14 references indexed in Scilit: